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Abstract
Background: Dexamethasone added to local anesthetic for brachial plexus block improves postoperative pain after
arthroscopic rotator cuff repair, as compared with the use of local anesthetic alone. Dexamethasone is present in
non-particulate form in local anesthetic solution, while betamethasone is partially present in particulate form. The
particulate betamethasone gradually decays and is expected to cause its longer-lasting effect. This study investigated
the postoperative analgesic effect of betamethasone added to ropivacaine for brachial plexus block in patients who
underwent arthroscopic rotator cuff repair.
Methods: This was a prospective, randomized, triple-blind study of 44 patients undergoing arthroscopic rotator cuff
repair surgery. Ultrasound-guided interscalene brachial plexus block, involving 20 mL of 0.375 % ropivacaine (group R)
or 19 mL of 0.375 % ropivacaine with 4 mg (1 mL) of betamethasone (group BR), was administered and surgery was
performed under general anesthesia. After surgery, the pain score was recorded at 12 h after surgery, and on the first,
second, and seventh postoperative day. Analgesia duration, offset time of motor block, frequency of rescue analgesic
administration, postoperative nausea/vomiting, and sleep disturbance during the night after surgery were recorded.
The numerical values were expressed as median [interquartile range]. P values < 0.05 were considered statistically
significant.
Results: The duration of analgesia was significantly prolonged in group BR (group BR: 19.1 h [16.6, 20.9 h], group R: 13.
3 h [11.6, 16.5 h], p < 0.001). The pain scores at 12 h after surgery and on the first and seventh day after surgery were
significantly lower in group BR than in group R. The duration of motor block was significantly prolonged in group BR.
The frequency of rescue analgesic administration and the sleep disturbance rate were significantly lower in group BR.
There was no difference in postoperative nausea/vomiting between the two groups.
Conclusions: Betamethasone added to local anesthetic in interscalene brachial plexus block improved postoperative
pain after arthroscopic rotator cuff repair, and betamethasone prolonged the duration of analgesia by almost 6 h.
Trial registration: University Hospital Medical Information Network Center Clinical Trials Registration System
(UMIN000012899).
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Background
Pain control after arthroscopic rotator cuff repair is chal-
lenging for anesthesiologists [1], but interscalene bra-
chial plexus block has been shown to offer effective pain
relief after this procedure [1]. Continuous nerve block
may be ideal for prolonging the analgesic effect, but it
may cause unexpected events, such as catheter migra-
tion, leakage of anesthetics, and infection [2–6]. In most
cases, arthroscopic shoulder surgery is performed as out-
patient surgery, and management of ambulatory cathe-
ters is an important consideration in this context. On
the other hand, a single injection of anesthetics offers
analgesia for a limited duration.
Dexamethasone added to local anesthetic for brachial
plexus block improves postoperative pain after arthro-
scopic rotator cuff repair, as compared with the use of
local anesthetic alone [7–14].
In this study, we used betamethasone instead of the
commonly used dexamethasone. Betamethasone is a
long-acting corticosteroid, and is a stereoisomer of dexa-
methasone. Steroids can be classified as particulate and
non-particulate, depending on their solubility and aggre-
gation characteristics. Dexamethasone is present only in
non-particulate form in saline, while betamethasone is
present in both particulate and non-particulate form,
depending on the composition of the solution [15].
Betamethasone is partially present in particulate form in
ropivacaine solution. The particulate steroid is thought
to act as a local reserve, which gradually decays and re-
leases the steroid, thereby causing its longer-lasting effect.
Betamethasone has been primarily utilized for periph-
eral nerve injections in patients with chronic pain, because
of its longer-lasting analgesia [16–19]. The conventional
dose of perineural betamethasone is 2–8 mg. We chose
4 mg of betamethasone as a perineural adjuvant.
This study aimed to evaluate the analgesic effect of
perineural betamethasone when added to ropivacaine in
an interscalene brachial plexus block.
Methods
This study was reviewed and approved by a local ethics
committee (Hino Municipal Hospital Ethical Review
Board; Reception. No. 25-11, approved on the 6 Mar
2014), and was registered in the University Hospital
Medical Information Network Center Clinical Trials
Registration System (UMIN000012899, registered on the
10 Mar 2014).
Informed consent was obtained from patients sched-
uled for arthroscopic rotator cuff repair from April 2014
to March 2015. Exclusion criteria were allergy against
local anesthetics, coagulation disorder, local skin infec-
tion at the block site, peripheral neuropathy, pre-existing
steroid administration, ASA physical status ≥ 4, and pa-
tient refusal. Patients were randomly divided in two
groups, with (group BR) or without addition of beta-
methasone (group R) to ropivacaine for the interscalene
plexus block.
A randomized, triple-blind selection of the groups was
performed. Two nurses prepared the solution for the
nerve block before the anesthesiologist entered the
operation room. The solution for group BR was a com-
bination of 9.5 mL of 0.75 % ropivacaine (Anapeine®
7.5 mg/mL, AstraZeneca, Osaka, Japan), 9.5 mL of sa-
line, and 4 mg (1 mL) of betamethasone (Rinderon®,
Shionogi Co., Osaka, Japan). Betamethasone was added
after the 0.375 % ropivacaine solution was prepared, as
steroid particles may precipitate when the ropivacaine
stock solution and betamethasone are mixed. The solu-
tion for group R was a combination of 10 mL of 0.75 %
ropivacaine and 10 mL of saline. The anesthesiologists,
orthopedic surgeons, and nurses in the ward remained
blinded to the patients’ group allocation until the end of
the study.
General anesthesia was induced by administrating
2 mg/kg of propofol and 100–200 μg of fentanyl intra-
venously. Then, a laryngeal mask (ProSeal™, Teleflex,
San Diego, CA, USA) was placed on the patient, and the
anesthesia was maintained with 4–6 % desflurane. An
ultrasound-guided interscalene plexus block was admin-
istered after placement of the laryngeal mask [20]. We
used a 6–13 Hz high-frequency linear probe (HFL 38x
EDGE, SonoSite Co., Bothell, WA, USA) for guiding the
block. The anesthesiologist placed the probe at the level
of C6 and identified the brachial plexus running between
the anterior and median scalene muscles. A 22G needle
(Stimplex® Ultra, B. Braun, Melsungen, Germany) was
used to administer the nerve block. Although the bra-
chial plexus was mostly identified only by ultrasound,
we used ultrasound and nerve stimulation if there was
any difficulty in identifying the brachial plexus [21, 22].
When the needle had been placed at the nerves between
C5 and C6, 20 mL of the prepared solution was injected
slowly. All nerve blocks were performed by anesthesiolo-
gists who were experts in administration of ultrasound-
guided nerve blocks. During surgery, ephedrine and/
or phenylephrine were administered to maintain ap-
propriate hemodynamics in the patients. At the end
of the surgery, 50 mg of flurbiprofen was routinely
administered intravenously. We verified whether the
nerve block was sufficient, by a pain score of zero,
sensory loss, and motor block after the patient’s
awakening from general anesthesia.
The primary outcome of this study was the duration of
analgesia, which was assessed by the time to first analgesic
request. Secondary outcome measures included offset time
for motor block, consumption of rescue analgesics, and the
presence of sleeping disturbance during the night after the
operation day were recorded (See: Additional file 1).
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Postoperative pain was scored on the Wong-Baker
Face Scale (scale range: 0–5; 0: no pain, 5: strongest
pain) on the day of surgery (12 h after surgery), as well
as on the first, second, and seventh postoperative day
(POD). Motor block was assessed on the modified
Lovett rating scale (0: complete paralysis, 1: almost
complete paralysis, 2: pronounced mobility impairment,
3: slight mobility impairment, 4: pronounced reduction
of muscular force, 5: slightly reduced muscular force, 6:
normal muscular force). Offset time for motor block was
measured as the time lapsed till returning to baseline
muscular force of thumb abduction (radial nerve),
thumb adduction (ulnar nerve), thumb opposition
(median nerve), and elbow flexion (musculocutaneous
nerve) [23]. The postoperative pain score and the motor
block rating scale were measured by nurses attending
the orthopedics ward.
The nurses were educated about stating the pain
scores and the neurologic evaluation prior to study com-
mencement. Postoperatively, the patients were allowed
to request rescue analgesics at any time, and received
diclofenac (25 mg p.r.) with at least a 6-h interval before
re-administration. If the diclofenac did not relieve the
pain, patients received pentazocine (15 mg i.v.) with an
interval of at least 30 min. On the first postoperative
day, the regular administration of 4 mg of oral lornoxicam
after each meal was started and continued until the fifth
postoperative day. Administration times and the amount
of analgesics used were recorded by the ward nurses.
Systemic or surgical site infection was evaluated by two
observers, an orthopedic surgeon not in charge of the pa-
tient, and an infection control nurse in the hospital.
Sample size was calculated from the data of time to
first analgesic request in a pilot study. The sample size
required for 80 % power at ɑ = 0.05 was estimated to be
22 patients each for the experimental and control group.
We used the Wilcoxon test to compare continuous vari-
ables and Fisher’s exact test to compare nominal vari-
ables. The numerical values were expressed as ratios (%)
or as the median (interquartile range). P values less than
0.05 were considered statistically significant. We per-
formed the log-rank test to compare the duration of the
analgesic effect. Statistical analyses were performed with
JMP 11 statistical software (JMP Statistical Discovery,
Cary, NC, USA).
Results
Forty-four patients participated in this study. No patient
was excluded using our criteria. All patients were
healthy (ASA physical status 1 or 2), and there was no
difference in the demographic data among the groups,
except for the sex ratio (Table 1). We performed a sub-
group analysis for each sex, but found no statistically
significant difference in the primary outcome measure.
There was no technical difficulty in identifying the
brachial plexus with ultrasound devices and the nerve
block was performed sufficiently in all cases. There were
no neurological complications or infections (systemic or
surgical site).
The duration of analgesia in group BR was significantly
longer than that in group R (group BR: 19.1 h [16.6,
20.9 h], group R: 13.3 h [11.6, 16.5 h], p < 0.001; Fig. 1).
The pain score in group BR was significantly lower
than that in group R at 12 h after surgery (group BR: 0.5
[0, 1], group R: 3.5 [1.75, 4.25], p < 0.001), on POD 1
(group BR: 2.0 [1, 2], group R: 3.0 [2, 4], p = 0.005) and
POD 7 (group BR: 1.0 [0, 1], group R: 2.0 [1, 2], p < 0.001),
but not on POD 2 (group BR: 1 [1, 2.25], group R 2[1, 3],
p = 0.18; Fig. 2).






Age (years) 65 (58,69) 65 (60,70) 0.25
Sex male/female 15/7 7/15 0.034*
ASA status 1/2 10/12 12/10 0.76
BMI 25 (23,27) 23 (19,25) 0.06
Right/Left 8/14 8/14 1.00
Anchors 3 (3,4) 3 (1.75,4) 0.25
Surgical time (min) 108 (90,133) 95 (74,115) 0.11
Fentanyl (mcg) 100 (100,163) 100 (100,150) 0.77
There was no difference in the demographic data, except for the sex ratio
All measured values are presented as median (interquartile range) or numbers
of patients. Group R: 0.375 % ropivacaine (20 mL), group BR: betamethasone
4 mg (1 mL) + 0.375 % ropivacaine (19 mL), ASA: American Society of
Anesthesiologist, BMI: Body mass index, Anchors: number of implanted
anchors. *P < 0.05. (See: Additional file 1)
Fig. 1 Duration of analgesia. The duration of analgesia in group BR
(solid line) was significantly longer than that in group R (dotted line).
R group: 0.375 % ropivacaine (20 mL), BR group: betamethasone 4 mg
(1 mL) + 0.375 % ropivacaine (19 mL)
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The frequency of sleep disturbance during the night
after surgery in group BR was significantly lower than
that in group R (group BR: 14 %, group R: 77 %, p < 0.001).
The amount of rescue analgesics in group BR was signifi-
cantly lower than that in group R (Table 2). The frequency
of nausea/vomiting in the groups was not significantly
different (Table 2).
The duration of the motor block in group BR was sig-
nificantly longer than that in group R (group BR: 13.9 h
[8.2, 18.1 h], group R: 10.4 h [3.9, 13.2 h], p = 0.004).
Discussion
Our study showed that perineural betamethasone added
to ropivacaine prolonged the duration of analgesia by al-
most 6 h. This is the first report to show a long-term
effect of particulate steroid when used as an anesthetic
adjuvant. Kawanishi et al. reported that dexamethasone
added to 0.75 % ropivacaine prolonged the duration of
analgesia by almost 7 h [14]. Our result also showed
prolonged analgesia duration using 0.375 % ropivacaine,
which was half of the concentration of ropivacaine used
in the paper by Kawanishi et al. [14].
Although the analgesia-prolonging effect of perineural
betamethasone was statistically significant at postopera-
tive day 7, the effect was slight. Therefore, the long-term
effect in terms of clinical efficacy remains unclear.
This was a randomized control study. We planned the
sample size used from the data obtained from a pilot
study. However, the sex distribution was statistically sig-
nificantly different between the two groups. In the post-
hoc statistical analysis based on gender, no significant
differences in primary outcome were obtained.
Infarction of the spinal cord due to using betametha-
sone for epidural analgesia has previously been reported
[24]. This was thought to be due to large particles of
betamethasone occluding the blood vessels supplying
the spinal cord. On the other hand, betamethasone has
been used clinically for nerve root blocks [25]. We
therefore speculate that perineural injection of beta-
methasone is safe.
Steroids also have anti-emetic effects [26, 27], but we
could not show this effect in the present study. It is pos-
sible that the amount of betamethasone used was too
little to exert an antiemetic effect. We surmise that beta-
methasone stayed at the injected site, and that the sys-
temic blood concentration may not have attained
sufficient levels to exert an anti-emetic effect.
This study had some limitations. We did not directly
compare betamethasone with dexamethasone. The dif-
ference in analgesic effect between betamethasone and
dexamethasone remains unknown. We chose to use
4 mg of betamethasone for this study. This dose was ar-
bitrarily chosen, given that the conventional dose of
betamethasone ranges from 2 to 8 mg. We did not perform
a proper dose-ranging study with betamethasone as a local
anesthetic adjuvant for an interscalene brachial plexus
block. Further studies are needed to elucidate the long-
term effect and optimal dose of particulate betamethasone.
Conclusions
Betamethasone added to ropivacaine in interscalene
brachial plexus block improves postoperative pain after
arthroscopic rotator cuff repair, and betamethasone
prolonged the duration of analgesia by almost 6 h.
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Additional file 1: This is raw data of our clinical research. This file
includes all our data of demographic data, primary outcome and
secondary outcome. (XLS 33 kb)
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Sleep disturbance 17 (77 %) 3 (14 %) <0.001
Rescue analgesics
Diclofenac (mg) 50 (18.5, 50) 0 (0. 6.3) <0.001
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